LY-139478

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameLY-139478
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulatorsApoptosis stimulants
TargetsEstrogen receptors
Therapy Area/IndicationsAtherosclerosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsAtherosclerosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A